Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2026-03-19

EMA Authorised: Aerius (desloratadine) — Organon N.V.

View source ↗

Summary

The European Medicines Agency has authorised Aerius (desloratadine), a non-sedating antihistamine for allergic rhinitis (perennial and seasonal) and urticaria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aerius (cetirizine)

Snippet

Status: Authorised. Therapeutic area: Rhinitis, Allergic, Perennial;Urticaria;Rhinitis, Allergic, Seasonal. MAH: Organon N.V.. Decision date: 26/02/2026